Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against <em>Schistosoma haematobium</em>: randomized,... (Publications)
properties, yet no clinical studies have been performed. METHODS: We conducted a randomized, exploratory open-label trial to assess the efficacy and safety of mefloquine (25 mg/kg), artesunate (3 doses of 4 mg/kg)
Chimney stoves modestly improved indoor air quality measurements compared with traditional open fire stoves: resulty from a small-scale intervention... (Publications)
Nearly half of the world's population depends on biomass fuels to meet domestic energy needs, producing high levels of pollutants responsible for substantial morbidity and mortality. We compare carbon
Open Calls (Page)
https://www.swisstph.ch/en/research/leading-house-africa/open-calls
Open Calls We are pleased to announce that the State Secretariat for Education, Research and Innovation (SERI) has renewed our Leading House Africa mandate for 2025–2028. We will soon provide updates on
Switch Either near Suppression Or THOusand – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with... (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/switch-either-near-suppression-or-thousand-switch-to-second-line-versus-who-guided-standard-of-care-for-unsuppressed-patients-on-first-line-art-with-viremia-below-1000-copies/ml-a-multicenter-open-label-randomized-clinical-trial
second-line ART in patients with sustained unsuppressed VL. Methods In this multicenter, parallel-group, open-label, randomized controlled trial conducted in Lesotho, patients on first-line, non-nucleoside reverse
Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre,... (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/efficacy-and-safety-of-fexinidazole-in-patients-with-human-african-trypanosomiasis-hat-due-to-trypanosoma-brucei-rhodesiense-a-multicentre-open-label-clinical-trial
A vector-borne parasitic illness, human African trypanosomiasis (HAT), also known as sleeping sickness, is usually fatal without treatment. The less prevalent form, T.b. rhodesiense (r-HAT), is concen
Global online training course for openIMIS (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/global-online-training-course-for-openimis
to the manifold OpenIMIS capacity building elements, by optimizing their structure, integrating them in a modular learning package and making them available as a self-paced certified OpenIMIS e-learning [...] well as new members of the OpenIMIS community on using the software. Contents and formats of the global implementation support will shape and convey the spirit of an engaging OpenIMIS community and its capacity [...] engaged stakeholders increases, adding to the organizational complexity of...
Massive Open Online Course on Insecticide Resistance Management (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/massive-open-online-course-on-insecticide-resistance-management
developing an online IRM training course or ‘MOOC’ (Massive Online Open Course). The IRM MOOC will be free for the participant and open to anyone, but will be specifically designed for, and promoted to
Animal-assisted psychotherapy for pediatric chronic pain: case series of an open pilot study to test initial feasibility and potential efficacy (Publications)
To date, however, AAIs have not been examined in pediatric chronic pain. METHODS: The aim of this open pilot study was to examine the initial feasibility of recruitment and potential efficacy of an an [...] revealed that patients and their parents had a positive attitude towards AAIs. CONCLUSION: Our initial open pilot study is the first to investigate AAIs in the context of pediatric chronic pain. Notably, we
